If a patient has discontinued use of the Inspire hypoglossal nerve stimulation system, should the implanted device be removed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Should the Inspire Device Be Removed if No Longer in Use?

No, the Inspire hypoglossal nerve stimulation device does not need to be routinely removed simply because a patient has discontinued use, unless there are specific clinical indications such as infection, pain, need for MRI incompatibility, poor cosmesis, or planned future procedures that would be complicated by the device.

Clinical Decision Framework

The decision to explant should be based on specific clinical indications rather than non-use alone. Current evidence supports a conservative approach:

Indications for Device Explantation

Based on available case series data, documented reasons for Inspire explantation include 1, 2:

  • Infection (most common adverse event requiring explantation at 0.378% within first year) 3
  • MRI incompatibility when future imaging is medically necessary 1
  • Significant pain or discomfort that cannot be managed conservatively
  • Poor cosmesis causing patient distress 1
  • Device malfunction requiring replacement rather than revision
  • Elective removal (becomes the most common indication by 3 years at 1.478%) 3

Reasons to Leave Device in Place

If the patient is simply not using the device but has no complications:

  • Low complication rates: Overall explantation rates are only 0.723% within the first year and 2.680% by 3 years, indicating the device is well-tolerated when left in situ 3
  • Surgical complexity: Explantation procedures are technically challenging with mean operative times of 88-163 minutes, and complications are significantly higher when attempting same-session reimplantation (p = 0.018) 4, 1
  • Potential for future use: Patients may choose to resume therapy, and the device remains functional if left in place
  • Guideline support: Current AASM guidelines emphasize continuation of therapy when feasible but do not mandate removal when discontinued 5

Important Caveats

Surgical planning considerations: If the patient requires future chest wall surgery, cardiac procedures, or frequent MRI imaging, proactive explantation discussion may be warranted 1.

Device monitoring: Even if not actively used, patients should be counseled about the presence of the implant for future medical procedures involving electrocautery or radiofrequency ablation, though recent evidence suggests monopolar electrocautery is safe when used away from the immediate device vicinity 6, 7.

Reimplantation challenges: Should the patient desire future reimplantation with updated technology, extensive scar tissue formation makes this technically difficult with higher complication rates 4.

Practical Approach

The device should remain in place unless:

  1. Active infection develops
  2. Patient experiences persistent pain or discomfort
  3. Future medical needs (MRI, surgery) are incompatible with the device
  4. Patient specifically requests removal for cosmetic or psychological reasons

Simply discontinuing use of the device is not an indication for explantation given the low risk of leaving it in place and the surgical complexity of removal.

budget:token_budget Tokens used: 3500 Tokens remaining: 196500

References

Research

Device-related outcomes following hypoglossal nerve stimulator implantation.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2024

Research

Safety and effectiveness in explantation and re-implantation of hypoglossal nerve stimulation devices.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2021

Guideline

evaluation and management of obstructive sleep apnea in adults hospitalized for medical care: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2025

Research

Management of a Hypoglossal Nerve, Upper Airway Stimulator in the Pain Patient: Safety Considerations.

Pain practice : the official journal of World Institute of Pain, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.